TEAS RF New Application

EMGALITY

Eli Lilly and Company

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)

Trademark/Service Mark Application, Principal Register

Serial Number: 87435081
Filing Date: 05/03/2017

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 87435081
MARK INFORMATION
*MARK \\TICRS\EXPORT17\IMAGEOUT 17\874\350\87435081\xml1\ RFA0002.JPG
SPECIAL FORM YES
USPTO-GENERATED IMAGE NO
LITERAL ELEMENT Emgality
COLOR MARK NO
*DESCRIPTION OF THE MARK
(and Color Location, if applicable)
The mark consists of a series of undulating dots in varying sizes stemming from the "i" in the literal element Emgality.
PIXEL COUNT ACCEPTABLE YES
PIXEL COUNT 750 x 466
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Eli Lilly and Company
*STREET Lilly Corporate Center
*CITY Indianapolis
*STATE
(Required for U.S. applicants)
Indiana
*COUNTRY United States
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
46285
PHONE 317 651 1346
FAX 317 276 1919
EMAIL ADDRESS XXXX
WEBSITE ADDRESS www.lilly.com
LEGAL ENTITY INFORMATION
TYPE corporation
STATE/COUNTRY OF INCORPORATION Indiana
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
FILING BASIS SECTION 1(b)
INTERNATIONAL CLASS 044 
*IDENTIFICATION Medical information services in the field of central nervous systems diseases and disorders
FILING BASIS SECTION 1(b)
ADDITIONAL STATEMENTS SECTION
MISCELLANEOUS STATEMENT The literal element is a coined, non-dictionary word with no English translation.
ATTORNEY INFORMATION
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317 651 1346
FAX 317 276 1919
EMAIL ADDRESS trademarks@lilly.com
AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
OTHER APPOINTED ATTORNEY John R. Rudolph, Sheldon Pontaoe, Douglas K. Norman, Steven P. Caltrider, Gilbert T. Voy
CORRESPONDENCE INFORMATION
NAME Bruce W. Longbottom
FIRM NAME Eli Lilly and Company
STREET Lilly Corporate Center
CITY Indianapolis
STATE Indiana
COUNTRY United States
ZIP/POSTAL CODE 46285
PHONE 317 651 1346
FAX 317 276 1919
*EMAIL ADDRESS trademarks@lilly.com
*AUTHORIZED TO COMMUNICATE VIA EMAIL Yes
FEE INFORMATION
APPLICATION FILING OPTION TEAS RF
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 275
*TOTAL FEE DUE 550
*TOTAL FEE PAID 550
SIGNATURE INFORMATION
SIGNATURE /blongbottom/
SIGNATORY'S NAME Bruce W. Longbottom
SIGNATORY'S POSITION Assistant General Counsel
SIGNATORY'S PHONE NUMBER 317 651 1346
DATE SIGNED 05/03/2017



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2018)


Trademark/Service Mark Application, Principal Register

Serial Number: 87435081
Filing Date: 05/03/2017

To the Commissioner for Trademarks:

MARK: Emgality (stylized and/or with design, see mark)

The literal element of the mark consists of Emgality.
The applicant is not claiming color as a feature of the mark. The mark consists of a series of undulating dots in varying sizes stemming from the "i" in the literal element Emgality.
The applicant, Eli Lilly and Company, a corporation of Indiana, having an address of
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317 651 1346(phone)
      317 276 1919(fax)
      XXXX (not authorized)

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

       International Class 005:  Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of Alzheimer's disease, anxiety disorders, atopic dermatitis, autoimmune diseases and disorders, axial spondyloarthritis, bone and skeletal diseases and disorders, cancer, cardiovascular diseases, central nervous system diseases and disorders, cluster headaches, Crohn's disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hypoglycemia, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, muscle diseases and disorders, neurodegenerative diseases and disorders, neurological disorders, pain, Parkinson's disease, Psoriatic arthritis, rheumatoid arthritis, Sjogren's syndrome, sleep disorders, spondyloarthropathy, systemic lupus erythematosus, ulcerative colitis; Diagnostic agents and substances for medical purposes; radiopharmaceutical diagnostic preparations for use in the diagnosis of neurodegenerative diseases
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

       International Class 044:  Medical information services in the field of central nervous systems diseases and disorders
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.



Miscellaneous Statement
The literal element is a coined, non-dictionary word with no English translation.

For informational purposes only, applicant's website address is: www.lilly.com

The applicant's current Attorney Information:
      Bruce W. Longbottom and John R. Rudolph, Sheldon Pontaoe, Douglas K. Norman, Steven P. Caltrider, Gilbert T. Voy of Eli Lilly and Company      Lilly Corporate Center
      Indianapolis, Indiana 46285
      United States
      317 651 1346(phone)
      317 276 1919(fax)
      trademarks@lilly.com (authorized)


The applicant's current Correspondence Information:
      Bruce W. Longbottom
      Eli Lilly and Company
      Lilly Corporate Center
      Indianapolis, Indiana 46285
      317 651 1346(phone)
      317 276 1919(fax)
      trademarks@lilly.com (authorized)
E-mail Authorization: I authorize the USPTO to send e-mail correspondence concerning the application to the applicant, the applicant's attorney, or the applicant's domestic representative at the e-mail address provided in this application. I understand that a valid e-mail address must be maintained and that the applicant or the applicant's attorney must file the relevant subsequent application-related submissions via the Trademark Electronic Application System (TEAS). Failure to do so will result in the loss of TEAS Reduced Fee status and a requirement to submit an additional processing fee of $125 per international class of goods/services.

A fee payment in the amount of $550 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /blongbottom/   Date: 05/03/2017
Signatory's Name: Bruce W. Longbottom
Signatory's Position: Assistant General Counsel
Payment Sale Number: 87435081
Payment Accounting Date: 05/04/2017

Serial Number: 87435081
Internet Transmission Date: Wed May 03 14:37:30 EDT 2017
TEAS Stamp: USPTO/BAS-XXX.XXX.XXX.XX-201705031437304
74368-87435081-5906acc697438b3d5675acf22
4eeb770e21d939dbdf6c5bafed8593ca8263e36c
-DA-921-20170503103815426833

TEAS RF New Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed